Glycemic variability and oxidative stress in patients with type 2 diabetes mellitus during combined glucose-lowering therapy

by S G Butaeva, A S Ametov, A V Bugrov, V V Dolgov
Published 2017-10-01

Diagnostic and prognostic role of PAPP-A and inflammatory markers in various forms of coronary heart disease

by A. O. Shevchenko, Yu. S. Slesareva, S. Al-Bustani, A. V. Bugrov, O. P. Shevchenko
Published 2010-06-01

Effect of combination antihypertensive therapy, including renin-angiotensin-aldosterone system inhibitors, on oxidative stress and arterial remodeling in hypertensive patients with...

by Z. M. Akhilgova, A. P. Roitman, N. G. Rakova, A. V. Bugrov, E. A. Pavlovskaya, M. S. Zastrozhin, A. G. Avtandilov
Published 2021-06-01

PREGNANCY-ASSOCIATED PLASMA PROTEIN A (PAPP-A) IN CARDIAC ALLOGRAFT VASCULOPATHY

by О. P. Shevchenko, O. V. Orlova, E. N. Kazakov, A. Y. Kormer, V. V. Chestukhin, B. L. Mironkov, A. V. Bugrov
Published 2011-06-01

PLASMA LEVEL OF SOLUBLE CD30 IN PEDIATRIC LIVING-DONOR LIVER TRANSPLANT PATIENT

by O. P. Shevchenko, O. M. Tsirulnikova, G. A. Olefirenko, M. E. Pishchulina, I. E. Tsirulnikova, A. V. Bugrov, A. A. Andrianova, S. V. Gautier
Published 2011-12-01